Scientists have developed a unique nanoparticle vaccine that prevented the development of multiple forms of cancer in mice, reports a study published in Cell Reports Medicine on Thursday.
Eighty percent of mice that received the novel vaccine and were subsequently exposed to cancerous cells did not develop tumors and survived to the end of the 250-day long experiment. In contrast, all of the mice that received different vaccine formulations, or remained unvaccinated, developed tumors and none survived longer than 35 days.
This post is for paid members only
Become a paid member for unlimited ad-free access to articles, bonus podcast content, and more.
Subscribe
Sign up for free access to this post
Free members get access to posts like this one along with an email round-up of our week's stories.
Subscribe
Already have an account? Sign in